We are live on ! Find out more
CF

Cantor Fitzgerald Portfolio holdings

AUM $6.78B
1-Year Est. Return 29.01%
This Fund
S&P 500
This Quarter Est. Return
+37.36%
1 Year Est. Return
+29.01%
3 Year Est. Return
+173.81%
5 Year Est. Return
10 Year Est. Return
AUM
$5.65B
AUM Growth
+$815M
Cap. Flow
+$67.8B
Cap. Flow %
1,200.39%
Top 10 Hldgs %
76.76%
Holding
563
New
241
Increased
80
Reduced
64
Closed
102

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$132M
2
MSTR icon
Strategy Inc
MSTR
+$86.9M
3
MSFT icon
Microsoft
MSFT
+$22.4M
4
IBIT icon
iShares Bitcoin Trust
IBIT
+$14.9M
5
BIDU icon
Baidu
BIDU
+$13.5M

Sector Composition

Rank Sector Weight
1 Technology 48.46%
2 Financials 5.41%
3 Consumer Discretionary 4.66%
4 Communication Services 3.55%
5 Healthcare 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVIIR
401
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$25.9K ﹤0.01%
184,988
-100
-0.1% -$10
ODV
402
DELISTED
Osisko Development Corp
ODV
$24.6K ﹤0.01%
11,500
CARV
403
DELISTED
Carver Bancorp
CARV
$23.3K ﹤0.01%
13,486
-21,171
-61% -$30.9K
CHPGR
404
ChampionsGate Acquisition Corp Rights
CHPGR
$21.1K ﹤0.01%
+210,624
New +$32.5K
XBPEW
405
XBP Europe Holdings Warrant
XBPEW
$21K ﹤0.01%
385,000
CAN
406
Canaan Creative
CAN
$178M
$20K ﹤0.01%
+32,365
New +$22.8K
BP icon
407
BP
BP
$107B
$19.8K ﹤0.01%
+661
New +$19.4K
TVGNW icon
408
Tevogen Bio Warrant
TVGNW
$9.64M
$18.2K ﹤0.01%
260,500
CAMP icon
409
CAMP4 Therapeutics
CAMP
$178M
$17.9K ﹤0.01%
+12,320
New +$24.5K
TDACW
410
Translational Development Acquisition Corp Warrants
TDACW
$16.5M
$17K ﹤0.01%
67,999
PFE icon
411
Pfizer
PFE
$144B
$16.7K ﹤0.01%
+688
New +$16K
OXLC
412
Oxford Lane Capital
OXLC
$854M
$16.4K ﹤0.01%
+782
New +$17.6K
SCWO icon
413
374Water
SCWO
$38.8M
$16.2K ﹤0.01%
+5,005
New +$16.8K
BZAIW
414
Blaize Holdings Warrants
BZAIW
$5.93M
$15K ﹤0.01%
39,099
LEGT.WS
415
DELISTED
Legato Merger Corp III Warrants
LEGT.WS
$13.5K ﹤0.01%
+50,000
New +$11.6K
BNZI icon
416
Banzai International
BNZI
$6.33M
$13.1K ﹤0.01%
111
WOLF icon
417
Wolfspeed
WOLF
$1.14B
$13K ﹤0.01%
+32,494
New +$74.1K
CGBSW
418
DELISTED
Crown LNG Holdings Limited Warrants
CGBSW
$12.4K ﹤0.01%
391,766
TAVIR
419
Tavia Acquisition Corp Right
TAVIR
$12.4K ﹤0.01%
+75,000
New +$11.6K
LMND.WS
420
DELISTED
Lemonade Inc Warrants
LMND.WS
$11.7K ﹤0.01%
139,251
EGHAR
421
EGH Acquisition Corp Rights
EGHAR
$11K ﹤0.01%
+50,000
New +$11K
CEROW
422
DELISTED
CERo Therapeutics Warrants
CEROW
$10.5K ﹤0.01%
441,048
PBMWW
423
Psyence Biomedical Warrant
PBMWW
$456K
$9.51K ﹤0.01%
468,500
BDMDW
424
Baird Medical Investment Holdings Warrant
BDMDW
$8.01K ﹤0.01%
100,000
APLT
425
DELISTED
Applied Therapeutics
APLT
$7.78K ﹤0.01%
25,000

Similar funds

Cantor Fitzgerald's Q2 2025 Portfolio in Review

As of Q2 2025, Cantor Fitzgerald held 563 positions worth $5.65B, up 17% from $4.83B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Cantor Fitzgerald deployed $67.8B of net new capital in Q2 2025, opening 241 new positions and adding to 80 existing holdings. Its largest new stake was Alibaba: 1,020,160 shares worth $116M.

By sector, the portfolio is most concentrated in Technology at 48% of assets, up from 42% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $132M trimmed.

  • Cantor Fitzgerald's largest Q2 2025 buy was Alibaba: 1,020,160 shares worth $116M.
  • Cantor Fitzgerald added most to Fidelity Wise Origin Bitcoin Fund in Q2 2025, an estimated $111M increase.
  • Cantor Fitzgerald's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $132M.
  • Cantor Fitzgerald fully exited Baidu in Q2 2025, selling an estimated $13.5M.
  • Cantor Fitzgerald's ten largest holdings make up 77% of its $5.65B portfolio in Q2 2025.
  • Cantor Fitzgerald opened 241 new positions and closed 102 in Q2 2025.
  • Cantor Fitzgerald's portfolio value rose 17% quarter-over-quarter to $5.65B.

Based on Cantor Fitzgerald's 13F filing for Q2 2025, filed 14 Aug 2025.